Roche Holding AG (SWX:RO)
Switzerland · Delayed Price · Currency is CHF 326.20
+3.40 (1.05%)
Nov 21, 2025, 5:30 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
614.90K CHF
Profits / Employee
91.32K CHF
Market Cap
270.06B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Lonza Group AG | 18,944 |
| Sonova Holding AG | 18,366 |
| Straumann Holding AG | 11,815 |
| Galenica AG | 7,971 |
Roche Holding AG News
- 3 days ago - Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution - Seeking Alpha
- 3 days ago - KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Business Wire
- 3 days ago - Roche: European Commission Grants Conditional Marketing Authorisation Of Lunsumio - Nasdaq
- 3 days ago - European Commission approves Roche's Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - GlobeNewsWire
- 4 days ago - Market bubbles cracking: Gold & defense stocks the go‑to strategy, says David Roche - CNBC
- 4 days ago - Why biotech and drug stocks are on the mend even though the rest of the market is hurting - Market Watch
- 4 days ago - RHHBY Reports Positive Phase III Data on Breast Cancer Drug - Nasdaq
- 4 days ago - Pharma Bro Martin Shkreli Shorts Olema Pharmaceuticals Stock - Benzinga